A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...
Immune signaling in IBD triggers tumor-promoting neutrophils which is linked to an increased risk of colorectal cancer.
The ‘TL1A’ messenger protein of the immune system triggers gut-to-bone marrow reaction, increasing the colorectal cancer risk ...
The results of research headed by a team in the lab of Michael Sigal, MD, at the Max Delbrück Center and Charité—Universitätsmedizin Berlin, have shed new light on the role of the p53 tumor suppressor ...
Several specific genetic mutations have been associated with colorectal cancer (CRC) and dysplasia in patients with ulcerative colitis (UC). [1] Many of these genetic alterations are unique to ...
Risk of venous thromboembolism and cardiovascular events in ulcerative colitis (UC) patients on advanced therapies were lower with vedolizumab (Entyvio) compared with TNF inhibitors in a real-world ...
News Medical on MSN
Discovery explains why people with IBD have higher risk of colorectal cancer
A chain of immune reactions in the gut—driven by a key signaling protein and a surge of white blood cells from the bone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results